ProQR Therapeutics' short term liquidity and more cash than ...
ProQR Therapeutics' short term liquidity and more cash than debt suggest it can manage its debt safely. Its 38% revenue growth is a positive sign, indicating potential for further strong growth.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more